Minimally differentiated acute myeloid leukemia (AML-MO): a distinct clinico-biologic entity with poor prognosis

@article{Amadori1996MinimallyDA,
  title={Minimally differentiated acute myeloid leukemia (AML-MO): a distinct clinico-biologic entity with poor prognosis},
  author={S. Amadori and Adriano Venditti and Giovanni del Poeta and Roberto Stasi and Francesco Buccisano and Antonio Bruno and Anna Tamburini and Maria Christina Cox and Laura E Maffei and Gaetano Aronica and Matilde De Simone and Gaspare Adorno and Mario Masi and Maurizio Tribalto and Giuseppe Papa},
  journal={Annals of Hematology},
  year={1996},
  volume={72},
  pages={208-215}
}
 FAB proposals for the diagnosis of AML-M0 represent the formal recognition of a distinct entity which has been described over the past few years by several authors and called minimally differentiated acute myeloid leukemia. By definition, AML-M0 includes acute leukemias which do not fit morphological and cytochemical criteria for the diagnosis of AML, and for which myeloid lineage assignment can be made by immunological assay showing positivity for MPO, CD13, and CD33 and negativity for… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 12 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 70 references

Dutch Slide Review Committee of Leukemia in Adults) (1995) AML-M0:clinical entity or waste basket for immature blastic leukemias? A description of 14 patients

  • CM Segeren, GCMM de Jong-Gerritis, MB van’t Veer
  • Ann Hematol
  • 1995
Highly Influential
8 Excerpts

Similar Papers

Loading similar papers…